Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 441-450 of 11534

Edit search filters
  1. A Phase 2b Study In Subjects With Alcoholic Hepatitis To Evaluate Safety And Efficacy Of DUR-928 Treatment

    Scottsdale/Phoenix, AZ

  2. A Study To Assess The Safety And Tolerability Of Single And Multiple Doses Of KAN-101 In Celiac Disease Patients

    Rochester, MN

  3. Protonix Treatment Of Maintenance Of Healing In Pediatric Participants Aged 1-11 Years And 12-17 Years

    Rochester, MN

  4. Quanta Home Run Trial

    Rochester, MN

  5. Marani Health M Care Study

    Rochester, MN

  6. Phase 3 Study Of Daraxonrasib (RMC-6236) In Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study To Evaluate The Safety And Effectiveness Of The Multi-Electrode Radiofrequency Balloon Catheter For The Treatment Of Symptomatic Paroxysmal Atrial Fibrillation

    Rochester, MN

  8. A Study Investigating The Safety, Tolerability, Pharmacokinetics, And Effectiveness Of Mosunetuzumab (BTCT4465A) In Combination With CHOP Or CHP-Polatuzumab Vedotin In Participants With B-Cell Non-Hodgkin Lymphoma

    Rochester, MN

  9. A Study To Evaluate The Safety Of Bone Marrow-Derived Stem Cells For Interstitial Lung Disease In Patients With Connective Tissue Disorders

    Jacksonville, FL

  10. A Study To Evaluate Gilteritinib Vs. Midostaurin In FLT3 Mutated Acute Myeloid Leukemia

    Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer